Skip to Content

CLOTBUST-ER Trial

Objective

CLOTBUST-ER Trial: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study of the Combined Lysis of Thrombus with Ultrasound and Systemic Tissue Plasminogen Activator (tPA) for Emergent Revascularization (CLOTBUST-ER) in Acute Ischemic Stroke.

 

For more information:

Overlake Medical Clinics Neurosurgery

Principal Investigator(s)
Abhineet Chowdhary, MD

Clinical Trial Categories

  • Neurosurgery
Contact
Tina Fortney, RN, CCRC at 425-688-5407

Location

  • Overlake Hospital Medical Center
    1035 116th Ave. NE
    Bellevue, WA 98004
    Main: 425-688-5000